Infection Clinical Trial
Official title:
Daytime Variation of Complication in Gastric and Pancreatic Surgery : a Single Center Randomized Study
Evaluate the daytime variation of complications in gastric and pancreatic surgery
The trial is funded by Cancer Foundation of China. The trial is prepared to be registered on
the clinicaltrails.gov. Quality assurance plan: every participant is enrolled or excluded by
two practiced investigators. And two investigators participated in all steps of the trail,
including the record of the data, and the investigators will compare the data. If the data is
consistent, the investigators would record the data; if not, the data would be checked and
decided by the two investigators. All the steps and data are site monitored and audited by
the workers of research and financial department of National Cancer Center/ Cancer Hospital,
Chinese Academy of Medical Sciences. Data check: the investigators compare data entered into
the registry against predefined rules for range or consistency with other data fields in the
registry. Source data verification to assess the accuracy, completeness, or
representativeness of registry data by comparing the data to external data sources, including
medical records and electronic case report forms. Data dictionary that contains detailed
descriptions of each variable used by the registry, including the source of the variable,
coding information, and normal ranges if relevant.
Standard Operating Procedures to address registry operations and analysis activities, such as
participants recruitment, data collection, data management, data analysis, reporting for
adverse events, and change management. All registry operations would be done according to
specific steps, and by two practiced investigators. Sample size assessment to specify the
number of participants or participant years necessary to demonstrate an effect. According to
the formula to differ advantages and disadvantages, the investigators need at least 200
participants to take part in the trail.
The investigators can recruit about 600 participants every year according to previous
experiences, so the investigators should recruit at least for half a year. Plan for missing
data: the investigators would collect as much data as possible, and the investigators exclude
the participants who cannot cooperate on recruitment. And the investigators manage situations
according to statistical principles where variables are reported as missing, unavailable,
"non-reported," uninterpretable, or considered missing because of data inconsistency or
out-of-range results. Statistical analysis plan: Kaplan-Meier method would be used to analyze
the difference of complications between the three groups, and the local control rate of the
three groups would be compared by chi square test. Statistical analyses would be performed by
using International Business Machine Statistical Product and Service Solutions
Statistics(version 20; IBM, Chicago, USA). The level of significance is defined as P < 0.05.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |